VPS25 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.323000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.793600E-01
Normal-vs-Stage2
7.899400E-01
Normal-vs-Stage3
5.719200E-01
Normal-vs-Stage4
7.004600E-01
Stage1-vs-Stage2
6.132000E-01
Stage1-vs-Stage3
2.499000E-01
Stage1-vs-Stage4
8.853600E-01
Stage2-vs-Stage3
1.298800E-01
Stage2-vs-Stage4
8.094400E-01
Stage3-vs-Stage4
2.498400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.349400E-01
Normal-vs-AfricanAmerican
7.856600E-01
Normal-vs-Asian
9.673000E-01
Caucasian-vs-AfricanAmerican
9.546600E-01
Caucasian-vs-Asian
4.716000E-01
AfricanAmerican-vs-Asian
6.049200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.999600E-01
Normal-vs-Female
6.626000E-01
Male-vs-Female
6.111200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.903800E-01
Normal-vs-Age(41-60Yrs)
5.632600E-01
Normal-vs-Age(61-80Yrs)
8.748800E-01
Normal-vs-Age(81-100Yrs)
7.240600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.637800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.489700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.737200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.106400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.368600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.744600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.854800E-01
Normal-vs-Daily Drinker
9.556000E-01
Normal-vs-Weekly Drinker
8.613000E-01
Normal-vs-Occasional Drinker
3.491800E-01
Normal-vs-Social Drinker
5.155200E-01
Non Drinker-vs-Daily Drinker
9.553600E-01
Non Drinker-vs-Weekly Drinker
7.985800E-01
Non Drinker-vs-Occasional Drinker
1.052610E-01
Non Drinker-vs-Social Drinker
2.504600E-01
Daily Drinker-vs-Weekly Drinker
8.311800E-01
Daily Drinker-vs-Occasional Drinker
6.321800E-02
Daily Drinker-vs-Social Drinker
1.930750E-01
Weekly Drinker-vs-Occasional Drinker
1.188240E-01
Weekly Drinker-vs-Social Drinker
2.961800E-01
Occasional Drinker-vs-Social Drinker
7.217000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.020600E-01
Normal-vs-Grade 2
6.882200E-01
Normal-vs-Grade 3
6.167200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.902600E-01
Grade 1-vs-Grade 3
6.312400E-01
Grade 1-vs-Grade 4
3.020600E-01
Grade 2-vs-Grade 3
1.151830E-01
Grade 2-vs-Grade 4
6.882200E-01
Grade 3-vs-Grade 4
6.167200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.797200E-01
Normal-vs-NonDiabetic
5.592600E-01
Diabetic-vs-NonDiabetic
2.142200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.156200E-01
Normal-vs-NoPancreatitis
7.461800E-01
Pancreatitis-vs-NoPancreatitis
4.958800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.961000E-01
Normal-vs-N1
8.273400E-01
N0-vs-N1
2.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.169400E-01
Normal-vs-TP53-NonMutant
8.974800E-01
TP53-Mutant-vs-TP53-NonMutant
5.425800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
